Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 140

1.

Studies on combination of oxaliplatin and dendrosomal nanocurcumin on proliferation, apoptosis induction, and long non-coding RNA expression in ovarian cancer cells.

Seyed Hosseini E, Alizadeh Zarei M, Babashah S, Nakhaei Sistani R, Sadeghizadeh M, Haddad Kashani H, Amini Mahabadi J, Izadpanah F, Atlasi MA, Nikzad H.

Cell Biol Toxicol. 2018 Nov 26. doi: 10.1007/s10565-018-09450-8. [Epub ahead of print]

PMID:
30478652
2.

Core-shell microencapsulation of curcumin in PLGA microparticles: programmed for application in ovarian cancer therapy.

Dwivedi P, Yuan S, Han S, Mangrio FA, Zhu Z, Lei F, Ming Z, Cheng L, Liu Z, Si T, Xu RX.

Artif Cells Nanomed Biotechnol. 2018 Oct 9:1-11. doi: 10.1080/21691401.2018.1499664. [Epub ahead of print]

PMID:
30299174
3.

Food-derived polyphenols inhibit the growth of ovarian cancer cells irrespective of their ability to induce antioxidant responses.

Kwon Y.

Heliyon. 2018 Aug 29;4(8):e00753. doi: 10.1016/j.heliyon.2018.e00753. eCollection 2018 Aug.

4.

Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties.

Hatamipour M, Ramezani M, Tabassi SAS, Johnston TP, Ramezani M, Sahebkar A.

J Cell Physiol. 2018 Dec;233(12):9247-9260. doi: 10.1002/jcp.27029. Epub 2018 Aug 4. Review.

PMID:
30076727
5.

Co-Delivery of Triptolide and Curcumin for Ovarian Cancer Targeting Therapy via mPEG-DPPE/CaP Nanoparticle.

Liu L, Xiong X, Shen M, Ru D, Gao P, Zhang X, Huang C, Sun Y, Li H, Duan Y.

J Biomed Nanotechnol. 2018 Oct 1;14(10):1761-1772. doi: 10.1166/jbn.2018.2633.

PMID:
30041722
6.

Oxidative stress in female cancers.

Calaf GM, Urzua U, Termini L, Aguayo F.

Oncotarget. 2018 May 4;9(34):23824-23842. doi: 10.18632/oncotarget.25323. eCollection 2018 May 4. Review.

7.

Curcumin in Advancing Treatment for Gynecological Cancers with Developed Drug- and Radiotherapy-Associated Resistance.

Momtazi-Borojeni AA, Mosafer J, Nikfar B, Ekhlasi-Hundrieser M, Chaichian S, Mehdizadehkashi A, Vaezi A.

Rev Physiol Biochem Pharmacol. 2018 May 5. doi: 10.1007/112_2018_11. [Epub ahead of print]

PMID:
29728868
8.

RCP induces FAK phosphorylation and ovarian cancer cell invasion with inhibition by curcumin.

Choe SR, Kim YN, Park CG, Cho KH, Cho DY, Lee HY.

Exp Mol Med. 2018 Apr 27;50(4):52. doi: 10.1038/s12276-018-0078-1.

9.

Beneficial effects of curcumin and capsaicin on cyclophosphamide-induced premature ovarian failure in a rat model.

Melekoglu R, Ciftci O, Eraslan S, Cetin A, Basak N.

J Ovarian Res. 2018 Apr 26;11(1):33. doi: 10.1186/s13048-018-0409-9.

10.

Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers.

Gawde KA, Sau S, Tatiparti K, Kashaw SK, Mehrmohammadi M, Azmi AS, Iyer AK.

Colloids Surf B Biointerfaces. 2018 Jul 1;167:8-19. doi: 10.1016/j.colsurfb.2018.03.046. Epub 2018 Mar 28.

PMID:
29625422
11.

The effects of Curcuma longa and curcumin on reproductive systems.

Mohebbati R, Anaeigoudari A, Khazdair MR.

Endocr Regul. 2017 Oct 26;51(4):220-228. doi: 10.1515/enr-2017-0024.

PMID:
29232190
12.

Chemopreventive and Antitumor Efficacy of Curcumin in a Spontaneously Developing Hen Ovarian Cancer Model.

Sahin K, Orhan C, Tuzcu M, Sahin N, Tastan H, Özercan İH, Güler O, Kahraman N, Kucuk O, Ozpolat B.

Cancer Prev Res (Phila). 2018 Jan;11(1):59-67. doi: 10.1158/1940-6207.CAPR-16-0289. Epub 2017 Oct 31.

13.

The use of natural compounds for the targeting and chemoprevention of ovarian cancer.

Pistollato F, Calderón Iglesias R, Ruiz R, Aparicio S, Crespo J, Dzul Lopez L, Giampieri F, Battino M.

Cancer Lett. 2017 Dec 28;411:191-200. doi: 10.1016/j.canlet.2017.09.050. Epub 2017 Oct 7.

PMID:
29017913
14.

Dihydroartemisinin and Curcumin Synergistically Induce Apoptosis in SKOV3 Cells Via Upregulation of MiR-124 Targeting Midkine.

Zhao J, Pan Y, Li X, Zhang X, Xue Y, Wang T, Zhao S, Hou Y.

Cell Physiol Biochem. 2017;43(2):589-601. doi: 10.1159/000480531. Epub 2017 Sep 21.

15.
16.

Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers.

Luong D, Kesharwani P, Alsaab HO, Sau S, Padhye S, Sarkar FH, Iyer AK.

Colloids Surf B Biointerfaces. 2017 Sep 1;157:490-502. doi: 10.1016/j.colsurfb.2017.06.025. Epub 2017 Jun 21.

17.

Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma.

Bixel K, Saini U, Kumar Bid H, Fowler J, Riley M, Wanner R, Deepa Priya Dorayappan K, Rajendran S, Konishi I, Matsumura N, Cohn DE, Selvendiran K.

Int J Cancer. 2017 Nov 1;141(9):1856-1866. doi: 10.1002/ijc.30847. Epub 2017 Jul 24.

18.

Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy (Review).

Wei Y, Pu X, Zhao L.

Oncol Rep. 2017 Jun;37(6):3159-3166. doi: 10.3892/or.2017.5593. Epub 2017 Apr 20. Review.

PMID:
28440434
19.

Demethoxycurcumin inhibited human epithelia ovarian cancer cells' growth via up-regulating miR-551a.

Du Z, Sha X.

Tumour Biol. 2017 Mar;39(3):1010428317694302. doi: 10.1177/1010428317694302.

PMID:
28345465
20.

Polyvalent Folate-Dendrimer-Coated Iron Oxide Theranostic Nanoparticles for Simultaneous Magnetic Resonance Imaging and Precise Cancer Cell Targeting.

Luong D, Sau S, Kesharwani P, Iyer AK.

Biomacromolecules. 2017 Apr 10;18(4):1197-1209. doi: 10.1021/acs.biomac.6b01885. Epub 2017 Mar 9.

PMID:
28245646

Supplemental Content

Loading ...
Support Center